Docoh
Loading...

AUPH Aurinia Pharmaceuticals

News

From Benzinga Pro
Expert Ratings For Aurinia Pharmaceuticals
10 Dec 21
Analyst Ratings
Within the last quarter, Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed the following analyst ratings:
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
10 Dec 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Oppenheimer Upgrades Aurinia Pharmaceuticals to Outperform, Lowers Price Target to $31
10 Dec 21
News, Upgrades, Price Target, Analyst Ratings
Oppenheimer analyst Justin Kim upgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Perform to Outperform and lowers the price target from $33 to $31.
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis
9 Dec 21
Biotech, News, Health Care, Movers, Trading Ideas, General
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has posted
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
9 Dec 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Aurinia Announces Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN) Show Sustained Meaningful Reductions in Proteinuria Compared to Mycophenolate Mofetil (Mmf) and Low-dose Oral Corticosteroids Alone, the Active Study Control
9 Dec 21
News
Aurinia Pharmaceuticals Inc.
61 Biggest Movers From Yesterday
3 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator.
40 Stocks Moving In Thursday's Mid-Day Session
2 Dec 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'
61 Biggest Movers From Yesterday
23 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Mid-Afternoon Market Update: Dow Rises 200 Points; Niu Technologies Shares Slide
22 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Monday, the Dow traded up 0.59% to 35,811.07 while the NASDAQ fell 0.43% to 15,989.15. The S&P also rose, gaining 0.43% to 4,718.05.
Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher
22 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Monday, the Dow traded up 0.65% to 35,832.70 while the NASDAQ rose 0.67% to 16,164.51. The S&P also rose, gaining 0.87% to 4,738.91.
40 Stocks Moving In Monday's Mid-Day Session
22 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views
22 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Monday, the Dow traded up 0.77% to 35,876.58 while the NASDAQ rose 0.91% to 16,203.01. The S&P also rose, gaining 0.91% to 4,740.94.
Biotech Reporter Adam Feuerstein Tweets '$AUPH didn't just file a mixed shelf on Friday, it also entered into a $250M ATM stock sale agreement with Cantor Fitzgerald. The buyout speculation looks well past its expiration date.'
22 Nov 21
News
https://twitter.com/adamfeuerstein/status/1462791666771898368
20 Stocks Moving in Monday's Pre-Market Session
22 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per share.
What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
4 Nov 21
Analyst Ratings
Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Oppenheimer Maintains Perform on Aurinia Pharmaceuticals, Raises Price Target to $33
4 Nov 21
News, Price Target, Analyst Ratings
Oppenheimer analyst Justin Kim maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Perform and raises the price target from $32 to $33.
HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $40
4 Nov 21
News, Price Target, Analyst Ratings
HC Wainwright & Co. analyst Ed Arce maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and raises the price target from $35 to $40.
SVB Leerink Maintains Outperform on Aurinia Pharmaceuticals, Raises Price Target to $35
4 Nov 21
News, Price Target, Analyst Ratings
SVB Leerink analyst Joseph Schwartz maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Outperform and raises the price target from $28 to $35.
Aurinia Pharmaceuticals: Q3 Earnings Insights
3 Nov 21
Earnings, News
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the announcement.

Press releases

From Benzinga Pro
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
4 Jan 22
Press Releases
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (the "Company") today announced that members of the management team will participate in two upcoming virtual investor conferences. H.C. Wainwright Virtual BioConnect 2022
Thinking about buying stock in Ensysce Biosciences, Siyata Mobile, Evgo, Aurinia Pharmaceuticals, or Hall of Fame Resort & Entertainment?
9 Dec 21
Fintech, Opinion, Press Releases
NEW YORK, Dec. 9, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ENSC, SYTA, EVGO, AUPH, and HOFV.
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
9 Dec 21
Press Releases
- Study demonstrated a favorable risk/benefit profile over a three-year period, with safety comparable to AURORA 1, and sustained efficacy - - Topline results show sustained meaningful reductions in proteinuria
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference
10 Nov 21
Press Releases
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (the "Company") today announced that the company will deliver a corporate presentation during the 2021 Jefferies London Healthcare Conference -- November 16-19, 2021. The
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
3 Nov 21
Press Releases
$14.7 million in net revenue for the third quarter 2021 (122% increase from second quarter 2021) Steady increases in LUPKYNIS Patient Start Forms, Conversion Rates and Payer Coverage Addition of two preclinical assets
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis
1 Nov 21
Press Releases
- Longest available outcomes data with LUPKYNIS will be presented virtually during American College of Rheumatology (ACR) Convergence 2021; final results expected by the end of 2021 – - Updated interim analysis shows
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021
27 Oct 21
Press Releases
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (the "Company") today announced that it will release its third quarter 2021 financial results on Wednesday, November 3, 2021, before the markets open. Aurinia's management team
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021
26 Oct 21
Press Releases
Data to highlight the safety, tolerability and efficacy of LUPKYNIS in patients with lupus nephritis Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharma company committed to delivering
Thinking about buying stock in Phunware Inc, Aurinia Pharma, Pinterest, Paypal or Bloom Energy?
25 Oct 21
Opinion, Press Releases
NEW YORK, Oct. 25, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PHUN, AUPH, PINS, PYPL, and BE.